Summary of Schedule Reconciling Selected Non-GAAP Financial Measures

(unaudited, in millions, except for per share amounts)

Quarter Ended July 2, 2017

GAAP

Non-GAAP Adjustments

Non-GAAP

Net sales

$

458.1

$

—

$

458.1

Gross profit

$

292.7

$

—

$

292.7

Operating income

$

70.0

$

77.9

$

147.9

Net income

$

13.6

$

102.4

$

116.0

Diluted earnings per share

$

0.12

$

0.87

$

0.99

Consolidated Condensed Statements of Income

(unaudited, in millions, except for per share amounts)

Quarter Ended

Nine Months Ended

Jul 2,
2017

Apr 2,
2017

Jul 3,
2016

Jul 2,
2017

Jul 3,
2016

Net sales

$

458.1

$

442.9

$

431.4

$

1,336.5

$

1,204.9

Cost of sales

165.4

158.8

164.5

483.2

549.6

Gross profit

$

292.7

$

284.1

$

266.9

$

853.3

$

655.3

Operating expenses

Selling, general and administrative

$

76.4

$

75.4

$

80.1

$

241.6

$

234.6

Research and development

85.1

86.9

83.0

254.3

225.7

Amortization of intangible assets

49.6

46.5

44.9

141.6

115.6

Restructuring, severance and facilities charges

11.2

5.8

4.9

19.4

58.3

Acquisition and divestiture related costs

0.4

0.4

2.8

1.5

31.2

Total operating expenses

$

222.7

$

215.0

$

215.7

$

658.4

$

665.4

Operating income (loss)

$

70.0

$

69.1

$

51.2

$

194.9

$

Interest and other expense, net

(58.7)

(26.2)

73.4

(112.1)

(51.2)

Income (loss) before income taxes

$

11.3

$

42.9

$

124.6

$

82.8

$

(61.3)

Provision for (benefit from) income taxes

(2.3)

1.7

9.4

8.5

11.8

Net income (loss)

$

13.6

$

41.2

$

115.2

$

74.3

$

(73.1)

Earnings (loss) per share

Basic

$

0.12

$

0.36

$

1.03

$

0.65

$

(0.69)

Diluted

$

0.12

$

0.35

$

1.00

$

0.64

$

(0.69)

Weighted-average common shares outstanding

Basic

115.0

114.7

112.1

114.7

105.3

Diluted

117.2

117.0

114.6

116.8

105.3